"Discovering new ways of cancer treatment Offering patients the hope they need with state-of-the-art treatment. We are here to help you every step of the way."

During the past decade, Connecticut Oncology Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Oncology Group" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Oncology Group" are "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Colonic Neoplasms" (1 trials), "Colorectal Neoplasms" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Connecticut Oncology Group" in a lesser frequency.

Most popular intervention types in "Connecticut Oncology Group" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dasatinib" (1 trials), "Docetaxel" (1 trials), "Erlotinib (tarceva)" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Oncology Group" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Connecticut Oncology Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Connecticut Oncology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Oncology Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".